Anthony Ea, DO
Cardiovascular Disease (Cardiology) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 5 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
16 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ea’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$327,450
Medicare paid this office $327,450 for 884 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 307 | $55,957 | $114 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 113 | $52,174 | $462 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 270 | $50,047 | $184 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 118 | $17,454 | $75 |
| Long return visit (40+ min) | 94 | $16,178 | $150 |
See all 25 services
| Return visit (30+ min) | 307 | $55,957 | $114 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 113 | $52,174 | $462 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 270 | $50,047 | $184 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 118 | $17,454 | $75 |
| Long return visit (40+ min) | 94 | $16,178 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $16,008 | $105 |
| Critical care, first 30-74 minutes | 23 | $11,711 | $186 |
| New patient visit (45+ min) | 65 | $9,597 | $148 |
| Short return visit (20+ min) | 105 | $9,587 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $9,371 | $71 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 130 | $8,310 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | $7,700 | $60 |
| Heart rhythm recording, analysis, interpretation and report of continous external ekg over more than 1 week up to 1 weeks | 23 | $7,021 | $293 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,206 | $151 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $5,373 | $283 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,886 | $114 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 232 | $4,818 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 214 | $2,883 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 12 | $2,568 | $214 |
| New patient visit (60+ min) | 16 | $2,559 | $160 |
| Injection, regadenoson, 0.1 mg | 71 | $1,602 | None |
| Programming of dual lead pacemaker system | 19 | $1,330 | $60 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $461 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 37 | $410 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 21 | $259 | $12 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 1-10 | None |
Who their Medicare patients are
884 Original Medicare patients in 2024. Average age 78 · Under 65 4% · 85 and older 24% · Women 47% · Also on Medicaid 14% · Health risk score 1.46. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 36% · Diabetes 35% · Heart failure 31% · Chronic kidney disease 29% · Cancer 19% · Depression 17% · COPD 15% · Dementia 13% · Stroke 13%.
The office billed $1,565,494, Medicare allowed $430,485 and paid $327,450; for 3,293 services of 65 kinds; $1,602 of it was for drugs given in the office and $325,848 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 884 | 3,293 | 78 | 1.46 | $1,565,494 | $327,450 |
| 2023 | 804 | 2,702 | 78 | 1.30 | $1,691,024 | $310,288 |
| 2022 | 753 | 2,824 | 78 | 1.33 | $1,859,273 | $334,440 |
| 2021 | 301 | 1,191 | 78 | 1.11 | $780,811 | $152,421 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 119 | $56,412 | $470 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $50,391 | $192 |
| Return visit (30+ min) | 206 | $31,659 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 78 | $24,225 | $107 |
| Long return visit (40+ min) | 112 | $23,501 | $165 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 125 | $17,416 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $10,626 | $156 |
| New patient visit (45+ min) | 66 | $9,598 | $145 |
| Injection, regadenoson, 0.1 mg | 59 | $9,474 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 134 | $9,074 | $67 |
| Critical care, first 30-74 minutes | 21 | $8,834 | $188 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 118 | $7,332 | $62 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $6,596 | $206 |
| New patient visit (60+ min) | 32 | $6,221 | $194 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 179 | $3,945 | $22 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $3,182 | $289 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,675 | $243 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 189 | $2,667 | $13 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,025 | $81 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 48 | $539 | $11 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $374 | $20 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 11 | $261 | $24 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 19 | $226 | $12 |
| Heart rhythm recording of continous external ekg over 8-15 days | 11 | $134 | $12 |
2022: 27 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 115 | $56,050 | $487 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 246 | $50,095 | $197 |
| Return visit (30+ min) | 194 | $32,435 | $119 |
| Long return visit (40+ min) | 139 | $29,663 | $159 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 118 | $19,868 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $18,436 | $91 |
| New patient visit (60+ min) | 79 | $15,276 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $11,636 | $179 |
| Injection, regadenoson, 0.1 mg | 53 | $10,279 | None |
| New patient visit (45+ min) | 65 | $9,898 | $152 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $9,672 | $71 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $9,141 | $208 |
| Critical care, first 30-74 minutes | 17 | $8,139 | $185 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,258 | $484 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $5,630 | $64 |
| Telephone medical discussion with physician, 21-30 minutes | 42 | $5,321 | $109 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 185 | $4,371 | $22 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $3,742 | $234 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 129 | $1,826 | $13 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 45 | $1,051 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 67 | $780 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $689 | $43 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 45 | $675 | $14 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 18 | $471 | $25 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $369 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 18 | $295 | $16 |
| Blood test, clotting time | 19 | $141 | $4 |
2021: 14 services
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 71 | $37,077 | $469 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 88 | $18,728 | $191 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 79 | $14,310 | $89 |
| Long return visit (40+ min) | 59 | $13,966 | $175 |
| Injection, regadenoson, 0.1 mg | 45 | $8,679 | None |
| New patient visit (60+ min) | 34 | $6,819 | $201 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $6,140 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,042 | $183 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 82 | $5,841 | $71 |
| Return visit (30+ min) | 33 | $4,662 | $126 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 31 | $2,090 | $65 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 85 | $2,023 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 46 | $647 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 25 | $295 | $11 |
Medicaid work
$1,047 in 2024
Medicaid paid $1,047 for 146 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 24 | $568 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 122 | $479 |
| 2024 | 146 | 2 | 47 | $1,047 |
| 2023 | 165 | 2 | 56 | $688 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 152 | $511 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $177 |
Drugs they prescribed that Part D paid
$680,501
Pharmacies billed $680,501 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,635) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,063 generic and 572 brand-name prescriptions · $680,501 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 144 | $182,077 | $1,264 |
| Entresto | 110 | $147,248 | $1,339 |
| Jardiance | 103 | $136,599 | $1,326 |
| Repatha Sureclick | 64 | $56,219 | $878 |
| Xarelto | 43 | $40,835 | $950 |
See all 33 drugs
| Eliquis | 144 | $182,077 | $1,264 |
| Entresto | 110 | $147,248 | $1,339 |
| Jardiance | 103 | $136,599 | $1,326 |
| Repatha Sureclick | 64 | $56,219 | $878 |
| Xarelto | 43 | $40,835 | $950 |
| Farxiga | 23 | $23,965 | $1,042 |
| Ozempic | 22 | $20,521 | $933 |
| Praluent | 11 | $11,429 | $1,039 |
| Metoprolol | 284 | $5,117 | $18 |
| Rosuvastatin | 341 | $4,924 | $14 |
| Amiodarone | 36 | $3,614 | $100 |
| Ezetimibe | 70 | $2,634 | $38 |
| Atorvastatin | 173 | $2,230 | $13 |
| Eplerenone | 26 | $2,033 | $78 |
| Carvedilol | 154 | $1,891 | $12 |
| Valsartan | 56 | $1,592 | $28 |
| Flecainide Acetate | 23 | $1,502 | $65 |
| Amlodipine Besylate | 150 | $1,139 | $8 |
| Spironolactone | 82 | $964 | $12 |
| Potassium Chloride | 40 | $926 | $23 |
| Clopidogrel | 62 | $911 | $15 |
| Losartan | 84 | $876 | $10 |
| Diltiazem 24hr Er (Cd) | 29 | $856 | $30 |
| Furosemide | 98 | $729 | $7 |
| Isosorbide Mononitrate Er | 40 | $720 | $18 |
| Bumetanide | 13 | $623 | $48 |
| Digoxin | 19 | $479 | $25 |
| Lisinopril | 45 | $334 | $7 |
| Metformin | 13 | $225 | $17 |
| Hydrochlorothiazide | 30 | $217 | $7 |
| Nitroglycerin | 13 | $133 | $10 |
| Benazepril | 13 | $130 | $10 |
| Metoprolol | 26 | $128 | $5 |
Year by year
| 2024 | 2,635 | 448 | 0% (0) | 22% | $680,501 |
| 2023 | 1,387 | 275 | 0% (0) | 15% | $292,654 |
| 2022 | 918 | 223 | 0% (0) | 20% | $186,206 |
| 2021 | 233 | 91 | None | 8% | $18,449 |
| 2020 | 227 | 69 | 0% (0) | 7% | $13,992 |
| 2019 | 225 | 49 | 0% (0) | 10% | $10,740 |
| 2018 | 204 | 50 | 0% (0) | 19% | $13,179 |
| 2017 | 35 | 14 | 0% (0) | None | $516 |
| 2016 | 27 | 16 | 0% (0) | None | $595 |
| 2015 | 104 | 46 | 0% (0) | 21% | $10,440 |
| 2014 | 11 | None | None | None | $613 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Eliquis | 71 | $97,332 | $1,371 |
| Entresto | 62 | $92,319 | $1,489 |
| Xarelto | 14 | $20,675 | $1,477 |
| Farxiga | 12 | $14,331 | $1,194 |
| Repatha Sureclick | 19 | $13,509 | $711 |
| Jardiance | 14 | $12,191 | $871 |
| Metoprolol | 160 | $3,534 | $22 |
| Rosuvastatin | 169 | $3,204 | $19 |
| Amiodarone | 18 | $2,472 | $137 |
| Ezetimibe | 19 | $1,973 | $104 |
| Atorvastatin | 129 | $1,931 | $15 |
| Valsartan | 30 | $1,530 | $51 |
| Carvedilol | 107 | $1,372 | $13 |
| Amlodipine Besylate | 111 | $1,210 | $11 |
| Isosorbide Mononitrate Er | 34 | $789 | $23 |
| Chlorthalidone | 17 | $650 | $38 |
| Clopidogrel | 35 | $588 | $17 |
| Potassium Chloride | 23 | $576 | $25 |
| Losartan | 43 | $549 | $13 |
| Spironolactone | 33 | $414 | $13 |
| Furosemide | 48 | $411 | $9 |
| Lisinopril | 39 | $319 | $8 |
| Ranolazine Er | 14 | $296 | $21 |
| Metoprolol | 20 | $139 | $7 |
| Hydrochlorothiazide | 13 | $36 | $3 |
2022: 20 drugs
| Eliquis | 74 | $91,337 | $1,234 |
| Entresto | 33 | $44,359 | $1,344 |
| Repatha Sureclick | 12 | $8,841 | $737 |
| Brilinta | 12 | $8,711 | $726 |
| Rosuvastatin | 81 | $2,902 | $36 |
| Atorvastatin | 88 | $2,056 | $23 |
| Metoprolol | 110 | $1,886 | $17 |
| Carvedilol | 54 | $681 | $13 |
| Clopidogrel | 50 | $535 | $11 |
| Valsartan | 11 | $529 | $48 |
| Potassium Chloride | 13 | $464 | $36 |
| Isosorbide Mononitrate Er | 15 | $462 | $31 |
| Losartan | 32 | $364 | $11 |
| Chlorthalidone | 15 | $314 | $21 |
| Furosemide | 56 | $278 | $5 |
| Amlodipine Besylate | 72 | $270 | $4 |
| Spironolactone | 23 | $260 | $11 |
| Hydrochlorothiazide | 14 | $118 | $8 |
| Metoprolol | 24 | $100 | $4 |
| Lisinopril | 26 | $81 | $3 |
2021: 5 drugs
| Brilinta | 11 | $9,821 | $893 |
| Clopidogrel | 70 | $1,092 | $16 |
| Rosuvastatin | 15 | $442 | $29 |
| Carvedilol | 15 | $219 | $15 |
| Atorvastatin | 19 | $148 | $8 |
2020: 6 drugs
| Rosuvastatin | 21 | $759 | $36 |
| Clopidogrel | 37 | $597 | $16 |
| Carvedilol | 23 | $387 | $17 |
| Isosorbide Mononitrate Er | 12 | $169 | $14 |
| Lisinopril | 15 | $109 | $7 |
| Amlodipine Besylate | 12 | $67 | $6 |
2019: 8 drugs
| Rosuvastatin | 15 | $1,010 | $67 |
| Clopidogrel | 35 | $400 | $11 |
| Metoprolol | 12 | $331 | $28 |
| Carvedilol | 17 | $254 | $15 |
| Lisinopril | 21 | $235 | $11 |
| Atorvastatin | 15 | $211 | $14 |
| Isosorbide Mononitrate Er | 17 | $139 | $8 |
| Amlodipine Besylate | 12 | $128 | $11 |
2018: 4 drugs
| Xarelto | 15 | $8,815 | $588 |
| Metoprolol | 27 | $595 | $22 |
| Clopidogrel | 15 | $154 | $10 |
| Lisinopril | 15 | $80 | $5 |
2015: 1 drug
| Prednisone | 21 | $70 | $3 |
Money from drug and device companies
$22,535 in 2025
| 2025 | 16 | 98 | $18,813 | $22,535 |
| 2024 | 10 | 35 | None | $1,083 |
| 2023 | 12 | 24 | None | $1,182 |
| 2022 | 9 | 19 | None | $476 |
| 2021 | 8 | 16 | None | $512 |
| 2020 | 5 | 9 | None | $4,481 |
| 2019 | 3 | 10 | None | $1,016 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Amplatzer | $20,435 | 56 payments
|
| Philips North America | Coronary Other | $881 | 9 payments
|
| Medtronic | Aurora Ev-Icd Mri Surescan | $254 | 3 payments
|
| Boston Scientific | Watchman Flx | $219 | 4 payments
|
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $142 | 5 payments
|
See all 98 published payments
| Abbott Laboratories | Meals · 2025-12-31 | Cardiomems | $158 |
| Novartis Pharmaceuticals | Meals · 2025-12-15 | Leqvio | $25 |
| Biosense Webster | Meals · 2025-12-12 | Carto 3 | $147 |
| Medtronic | Meals · 2025-12-12 | Aurora Ev-Icd Mri Surescan | $113 |
| Esperion Therapeutics | Meals · 2025-12-04 | Nexletol | $23 |
| Abbott Laboratories | Meals · 2025-11-18 | Cardiomems | $22 |
| Abbott Laboratories | Meals · 2025-11-18 | Cardiomems | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-11-13 | Jardiance | $28 |
| Abbott Laboratories | Meals · 2025-11-11 | Amplatzer Amulet | $23 |
| Abbott Laboratories | Meals · 2025-11-07 | Cardiomems | $160 |
| Abbott Laboratories | Consulting · 2025-11-05 | Amplatzer | $88 |
| Abbott Laboratories | Consulting · 2025-11-05 | Amplatzer | $88 |
| Novartis Pharmaceuticals | Meals · 2025-11-04 | Leqvio | $30 |
| Abbott Laboratories | Consulting · 2025-10-30 | Amplatzer | $263 |
| Abbott Laboratories | Consulting · 2025-10-30 | Amplatzer | $88 |
| Abbott Laboratories | Consulting · 2025-10-30 | Amplatzer | $88 |
| Abbott Laboratories | Consulting · 2025-10-30 | Amplatzer | $263 |
| Abbott Laboratories | Consulting · 2025-10-30 | Amplatzer | $88 |
| Philips North America | Meals · 2025-10-24 | Igt Devices Undivided | $61 |
| Philips North America | Meals · 2025-10-22 | Igt Devices Undivided | $43 |
| Cleerly | Meals · 2025-10-21 | Cleerly Ischemia | $16 |
| Alnylam Pharmaceuticals | Meals · 2025-10-16 | Amvuttra | $35 |
| Novo Nordisk | Meals · 2025-10-14 | Wegovy | $21 |
| Medtronic | Meals · 2025-10-14 | Aurora Ev-Icd Mri Surescan | $58 |
| Abbott Laboratories | Consulting · 2025-10-14 | Amplatzer | $88 |
| Abbott Laboratories | Consulting · 2025-10-14 | Amplatzer | $350 |
| Abbott Laboratories | Consulting · 2025-10-14 | Amplatzer | $963 |
| Abbott Laboratories | Consulting · 2025-10-14 | Amplatzer | $175 |
| Abbott Laboratories | Consulting · 2025-10-14 | Amplatzer | $263 |
| Amgen | Meals · 2025-10-07 | Repatha | $31 |
| Medtronic | Meals · 2025-10-01 | Omniasecure Mri Surescan | $82 |
| Pfizer | Meals · 2025-09-30 | Eliquis | $28 |
| Novartis Pharmaceuticals | Meals · 2025-09-25 | Leqvio | $35 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-23 | Jardiance | $17 |
| Novo Nordisk | Meals · 2025-09-12 | Wegovy | $23 |
| Octapharma USA | Meals · 2025-09-10 | Fibryga | $17 |
| Philips North America | Travel · 2025-08-28 | Igt Devices Undivided | $42 |
| Abbott Laboratories | Consulting · 2025-08-26 | Amplatzer Talisman | $350 |
| Abbott Laboratories | Consulting · 2025-08-26 | Amplatzer Talisman | $88 |
| Abbott Laboratories | Consulting · 2025-08-26 | Amplatzer Talisman | $1,225 |
| Abbott Laboratories | Consulting · 2025-08-26 | Amplatzer Talisman | $525 |
| Cordis US | Meals · 2025-08-15 | Mynx Control Venous | $20 |
| Abbott Laboratories | Meals · 2025-08-12 | Cardiomems | $124 |
| Boston Scientific | Meals · 2025-08-07 | Watchman Flx | $28 |
| Abbott Laboratories | Meals · 2025-08-07 | Cardiomems | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-05 | Eliquis | $19 |
| Abbott Laboratories | Meals · 2025-07-15 | Cardiomems | $31 |
| Cordis US | Meals · 2025-07-14 | Mynx Control Venous | $19 |
| Abbott Laboratories | Meals · 2025-07-09 | Cardiomems | $124 |
| Novartis Pharmaceuticals | Meals · 2025-06-26 | Leqvio | $23 |
| Abbott Laboratories | Consulting · 2025-06-26 | Amplatzer Talisman | $88 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-06-24 | Jardiance | $19 |
| Pfizer | Meals · 2025-06-17 | Eliquis | $24 |
| Abbott Laboratories | Meals · 2025-06-09 | Cardiomems | $34 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-29 | Jardiance | $31 |
| Abbott Laboratories | Meals · 2025-05-08 | Cardiomems | $41 |
| Abbott Laboratories | Meals · 2025-05-07 | Cardiomems | $111 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $1,138 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $175 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $1,138 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $1,838 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $88 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $875 |
| Abbott Laboratories | Consulting · 2025-04-29 | Amplatzer | $88 |
| Boston Scientific | Meals · 2025-04-26 | Watchman Flx | $20 |
| Philips North America | Meals · 2025-04-16 | Coronary Undivided | $40 |
| Pfizer | Meals · 2025-04-15 | Eliquis | $23 |
| Philips North America | Meals · 2025-04-15 | Coronary Undivided | $40 |
| Abbott Laboratories | Consulting · 2025-04-15 | Amplatzer | $1,225 |
| Abbott Laboratories | Consulting · 2025-04-15 | Amplatzer | $175 |
| Abbott Laboratories | Consulting · 2025-04-15 | Amplatzer | $175 |
| Abbott Laboratories | Consulting · 2025-04-15 | Amplatzer | $350 |
| Abbott Laboratories | Consulting · 2025-04-15 | Amplatzer | $263 |
| Abbott Laboratories | Meals · 2025-04-12 | Cardiomems | $73 |
| Abbott Laboratories | Meals · 2025-04-12 | Cardiomems | $113 |
| Abbott Laboratories | Meals · 2025-04-12 | Cardiomems | $95 |
| Abbott Laboratories | Travel · 2025-04-12 | Cardiomems | $50 |
| Abbott Laboratories | Travel · 2025-04-12 | Cardiomems | $20 |
| Abbott Laboratories | Travel · 2025-04-12 | Cardiomems | $9 |
| Abbott Laboratories | Meals · 2025-04-11 | Cardiomems | $50 |
| Abbott Laboratories | Meals · 2025-04-11 | Cardiomems | $149 |
| Philips North America | Travel · 2025-04-10 | Coronary Other | $24 |
| Philips North America | Travel · 2025-04-10 | Coronary Other | $303 |
| Philips North America | Travel · 2025-04-09 | Coronary Other | $24 |
| Philips North America | Travel · 2025-04-09 | Coronary Other | $305 |
| Abbott Laboratories | Meals · 2025-03-27 | Cardiomems | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-25 | Eliquis | $22 |
| Abbott Laboratories | Consulting · 2025-03-13 | Amplatzer | $1,925 |
| Abbott Laboratories | Consulting · 2025-03-13 | Amplatzer | $1,488 |
| Abbott Laboratories | Consulting · 2025-03-13 | Amplatzer | $2,800 |
| Abbott Laboratories | Meals · 2025-03-05 | Cardiomems | $20 |
| Abbott Laboratories | Meals · 2025-03-05 | Cardiomems | $4 |
| Novartis Pharmaceuticals | Meals · 2025-02-28 | Leqvio | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-20 | Camzyos | $22 |
| Boston Scientific | Meals · 2025-01-22 | Watchman Flx | $158 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-14 | Jardiance | $19 |
| Abbott Laboratories | Meals · 2025-01-14 | Cardiomems | $130 |
| Boston Scientific | Meals · 2025-01-07 | Watchman Flx | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,083
| Abbott Laboratories | Cardiomems | $448 | 12 payments
|
| Philips North America | (5044) Mcot | $225 | 10 payments
|
| Heartflow | Ffrct | $179 | 2 payments
|
| Boston Scientific | Watchman Flx | $53 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $48 | 2 payments
|
| Pfizer | Eliquis | $42 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $30 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $23 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $21 | 1 payment
|
| Esperion Therapeutics | Nexletol | $15 | 1 payment
|
2023: $1,182
| Abbott Laboratories | Cardiomems | $404 | 6 payments
|
| Medtronic | Onyx Frontier | $174 | 2 payments
|
| Novo Nordisk | None | $122 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $99 | 4 payments
|
| HeartFlow | Ffrct | $94 | 1 payment
|
| AngioDynamics | Bioflo | $85 | 1 payment
|
| Amgen | Repatha | $66 | 3 payments
|
| Boston Scientific | Lux-Dx Insertable Cardiac Monitor | $50 | 2 payments
|
| Philips Electronics North America | (5044) Mcot | $30 | 1 payment
|
| Merck Sharp & Dohme | Verquvo | $23 | 1 payment
|
| Pfizer | Eliquis | $20 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $17 | 1 payment
|
2022: $476
| AstraZeneca Pharmaceuticals LP | Farxiga | $169 | 4 payments
|
| Alnylam Pharmaceuticals | Onpattro | $74 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $59 | 3 payments
|
| Amgen | Repatha | $49 | 3 payments
|
| Esperion Therapeutics | Nexletol | $43 | 2 payments
|
| Pfizer | Eliquis | $23 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $22 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $20 | 1 payment
|
| Novo Nordisk | Ozempic | $16 | 1 payment
|
2021: $512
| Medtronic | Corevalve Evolut | $166 | 2 payments
|
| Abbott Laboratories | Esprit | $136 | 5 payments
|
| Edwards Lifesciences | None | $130 | 4 payments
|
| Amarin Pharma | Vascepa | $20 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Amgen | Repatha | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $13 | 1 payment
|
| Cardiovascular Systems | Diamondback Peripheral | $11 | 1 payment
|
2020: $4,481
| Medtronic Vascular | None | $2,600 | 1 payment
|
| Boston Scientific | General - Structural Heart | $1,229 | 3 payments
|
| Abbott Laboratories | Durata Defibrillation Icd Lead | $271 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $261 | 2 payments
|
| Siemens Medical Solutions USA | Artis Icono | $120 | 1 payment
|
2019: $1,016
| Medtronic Vascular | Corevalve Evolut | $403 | 3 payments
|
| Boston Scientific | General Therapies | $346 | 5 payments
|
| Abbott Laboratories | Mitra Clip System | $268 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700203221
- Licence
- CA 20A18586
- Trained
- Touro Un Col of Osteopathic Medicine, Henderson, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2490 Hospital Dr Ste 311, Mountain View, CA, 94040
- NPI first listed
- 2014-03-21
- NPI last updated
- 2022-05-05
- NPI record certified
- 2022-04-05
This is when the NPI record was last certified, not a medical board exam.